Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-25-107123
Filing Date
2025-04-30
Accepted
2025-04-30 16:04:48
Documents
17

Document Format Files

Seq Description Document Type Size
1 DEFR14A d74158ddefr14a.htm   iXBRL DEFR14A 461265
3 GRAPHIC g74158g01a03.jpg GRAPHIC 148248
4 GRAPHIC g74158g01a04.jpg GRAPHIC 179255
5 GRAPHIC g74158g17d21.jpg GRAPHIC 27792
6 GRAPHIC g74158g89a99.jpg GRAPHIC 38454
  Complete submission text file 0001193125-25-107123.txt   1755628

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vor-20241231.xsd EX-101.SCH 2487
19 EXTRACTED XBRL INSTANCE DOCUMENT d74158ddefr14a_htm.xml XML 5406
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-39979 | Film No.: 25894872
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)